Celltrion Eyes M&A, Global Expansion And Novel Drugs As Founder Returns

 
• By Jung Won Shin

Celltrion founder and chairman Jung Jin Seo has outlined why he has decided to return to the Korean biosimilars major and the business priorities for the group if it is to emerge as a top-tier global biopharma operation.

Celltrion Group Chairman Jung Jin Seo
Crucial Time For Celltrion’s Expansion In Global Territories • Source: Celltrion Group

With the official return of group chairman and founder Jung Jin Seo, this year will be crucial for Celltrion Group to expand its global territories, including the US, and to grow into a top-tier international biopharma firm by seizing opportunities in the current global economic environment.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Strategy

More from Business